Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10967629 | 0.81 | KDM4E (0.52) | KDM4EHPGDLMNAMEN1KMT2A | |
| SCHEMBL7734146 | 0.79 | KDM4E (1.00) | KDM4EHPGDLMNAMEN1KMT2A | |
| SCHEMBL7740418 | 0.79 | MEN1 (0.76) | KDM4EHPGDLMNAMEN1KMT2A | |
| SCHEMBL18831783 | 0.78 | SRC (0.48) | KDM4EHPGDLMNAMEN1KMT2A | |
| SCHEMBL9115028 | 0.76 | KDM4E (0.66) | KDM4EHPGDLMNAMEN1KMT2A | |
| SCHEMBL132235 | 0.75 | KDM4E (0.92) | KDM4EHPGDLMNAMEN1KMT2A | |
| SCHEMBL28445426 | 0.74 | SRC (0.46) | KDM4EMEN1KMT2AHTTCYP2C9 | |
| SCHEMBL5013978 | 0.74 | CA9 (0.48) | KDM4EHPGDHTTCYP1A2CYP2D6 | |
| SCHEMBL9439409 | 0.73 | KDM4E (0.50) | KDM4EHPGDHTTCYP1A2CYP2D6 | |
| SCHEMBL28384135 | 0.73 | KDM4E (0.50) | KDM4EHPGDHTTCYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013112585-A1 | SYNTHETIC METHODS PERTAINING TO TERT-BUTYL-BENZENE-BASED COMPOUNDS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-08-01 | — | — | WO | claimed |
| US-20130190525-A1 | SYNTHETIC METHODS PERTAINING TO TERT-BUTYL-BENZENE-BASED COMPOUNDS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-07-25 | — | — | US | claimed |
| US-7834130-B2 | Process for the production of polybenzimidazole from a tetraminobiphenyl and an isophthalic acid | PBI PERFORMANCE PRODUCTS, INC. (US) | 2010-11-16 | — | — | US | claimed |
| US-20080207869-A1 | PROCESS FOR THE PRODUCTION OF POLYBENZIMIDAZOLE FROM A TETRAMINOBIPHENYL AND AN ISOPHTHALIC ACID | PBI PERFORMANCE PRODUCTS, INC. | 2008-08-28 | — | — | US | claimed |
| CN-119742007-A | Method for screening DES (DES) by utilizing ANN and COSMO-RS and extracting oil tea polysaccharide based on DES combined with double-enzyme method | 四川农业大学 | 2025-04-01 | — | — | CN | disclosed |
| US-12107264-B2 | Anode active material comprising metal phosphide coating on surface of carbon material, preparation method therefor, nonaqueous lithium secondary battery comprising anode active material, and manufacturing method therefor | KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE (KR) | 2024-10-01 | — | — | US | disclosed |
| WO-2024075736-A1 | NITROGEN-CONTAINING COMPOUND, COMPOSITION COMPRISING SAID NITROGEN-CONTAINING COMPOUND, AND MARKER FOR PREDICTING TUMOR GRADE | 学校法人関西医科大学 | 2024-04-11 | — | — | WO | disclosed |
| US-20220216462-A1 | ANODE ACTIVE MATERIAL COMPRISING METAL PHOSPHIDE COATING ON SURFACE OF CARBON MATERIAL, PREPARATION METHOD THEREFOR, NONAQUEOUS LITHIUM SECONDARY BATTERY COMPRISING ANODE ACTIVE MATERIAL, AND MANUFACTURING METHOD THEREFOR | KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE (KR) | 2022-07-07 | — | — | US | disclosed |
| CN-114675458-A | High-performance hydrogen bond organic framework material electrochromic device | 辽宁大学 | 2022-06-28 | — | — | CN | disclosed |
| WO-2013112585-A1 | SYNTHETIC METHODS PERTAINING TO TERT-BUTYL-BENZENE-BASED COMPOUNDS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-08-01 | — | — | WO | disclosed |
| US-20130190525-A1 | SYNTHETIC METHODS PERTAINING TO TERT-BUTYL-BENZENE-BASED COMPOUNDS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-07-25 | — | — | US | disclosed |
| US-7834130-B2 | Process for the production of polybenzimidazole from a tetraminobiphenyl and an isophthalic acid | PBI PERFORMANCE PRODUCTS, INC. (US) | 2010-11-16 | — | — | US | disclosed |
| EP-0144290-A2 | Substituted ethylenediamine derivatives | CIBA-GEIGY AG (CH) | 1985-06-12 | — | — | EP | disclosed |
| EP-0143746-A2 | 5-Amino 4-hydroxy-valeryl-substituted derivatives | CIBA-GEIGY AG (CH) | 1985-06-05 | — | — | EP | disclosed |
| US-4483977-A | TETRAMINOBIPHENYL AND ISOPHTHALIC ACID | CELANESE CORPORATION (US) | 1984-11-20 | — | — | US | disclosed |
| EP-0111266-A2 | Substituted tetrapeptides | CIBA-GEIGY AG (CH) | 1984-06-20 | — | — | EP | disclosed |
| US-4452967-A | MELT POLYMERIZATION OF AROMATIC CARBOXY DIAMINE | CELANESE CORPORATION (US) | 1984-06-05 | — | — | US | disclosed |
| EP-0095348-A2 | High molecular weight polybenzimidazoles | CELANESE CORPORATION (US) | 1983-11-30 | — | — | EP | disclosed |
| US-4414383-A | High molecular weight polybenzimidazole preparation with phosphorus containing polymerization catalyst | CELANESE CORPORATION (US) | 1983-11-08 | — | — | US | disclosed |
| EP-0091130-A2 | Cephalosporin derivatives, process for preparing and pharmaceutical compositions containing said compounds | DAIICHI SEIYAKU CO., LTD. (JP) | 1983-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190525-A1 | SYNTHETIC METHODS PERTAINING TO TERT-BUTYL-BENZENE-BASED COMPOUNDS | TERT, HMBS, BET1 | KDM4E 467/4885HPGD 1887/4885LMNA 2560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.